ASND Ascendis Pharma AS

USD 148.44 -1.52 -1.013604
Icon

Ascendis Pharma AS (ASND) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 148.44

-1.52 (-1.01)%

USD 8.40B

0.24M

USD 169.33(+14.08%)

USD 133.00 (-10.40%)

Icon

ASND

Ascendis Pharma AS (USD)
COMMON STOCK | NSD
USD 148.44
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 8.40B

USD 133.00 (-10.40%)

USD 148.44

Ascendis Pharma AS (ASND) Stock Forecast

Show ratings and price targets of :
USD 169.33
(+14.08%)

Based on the Ascendis Pharma AS stock forecast from 7 analysts, the average analyst target price for Ascendis Pharma AS is USD 169.33 over the next 12 months. Ascendis Pharma AS’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Ascendis Pharma AS is Neutral, which is based on 4 positive signals and 4 negative signals. At the last closing, Ascendis Pharma AS’s stock price was USD 148.44. Ascendis Pharma AS’s stock price has changed by +2.92% over the past week, -4.44% over the past month and +36.74% over the last year.

No recent analyst target price found for Ascendis Pharma AS
No recent average analyst rating found for Ascendis Pharma AS

Company Overview Ascendis Pharma AS

Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company is also developing a pipeline of three independent endocrinology rare disease prod...Read More

200 Bay Street, Toronto, ON, Canada, M5J 2J2

879

December

USD

USA

Adjusted Closing Price for Ascendis Pharma AS (ASND)

Loading...

Unadjusted Closing Price for Ascendis Pharma AS (ASND)

Loading...

Share Trading Volume for Ascendis Pharma AS Shares

Loading...

Compare Performance of Ascendis Pharma AS Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for ASND

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Ascendis Pharma AS (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc -1.14 (-0.27%) USD107.38B 29.93 21.06

ETFs Containing ASND

Symbol Name ASND's Weight Expense Ratio Price(Change) Market Cap
MEDI
Harbor Health Care ETF 13.53 % 0.80 % +0.18 (+0.68%) USD6.79M

Frequently Asked Questions About Ascendis Pharma AS (ASND) Stock

Based on ratings from 7 analysts Ascendis Pharma AS's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Neutral. The stock has 7 buy, sell and 1 hold ratings.

Unfortunately we do not have enough data on ASND's stock to indicate if its a good dividend stock.

Based on targets from 7 analysts, the average taret price for ASND is USD 169.33 over the next 12 months. The maximum analyst target price is USD 260 while the minimum anlayst target price is USD 116.

ASND stock's Price/Earning ratio is 1.19. Our analysis grades ASND stock's Price / Earning ratio at D+. This means that ASND stock's Price/Earning ratio is above 31.00000000000001% of the stocks in the Biotechnology sector in the NSD exchange. Based on this ASND may be fairly valued for its sector

The last closing price of ASND's stock was USD 148.44.

The most recent market capitalization for ASND is USD 8.40B.

Based on targets from 7 analysts, the average taret price for ASND is projected at USD 169.33 over the next 12 months. This means that ASND's stock price may go up by +14.08% over the next 12 months.

Following are ETFs with the highest allocation to Ascendis Pharma AS's stock :

MEDI

As per our most recent records Ascendis Pharma AS has 879 Employees.

Ascendis Pharma AS's registered address is 200 Bay Street, Toronto, ON, Canada, M5J 2J2. You can get more information about it from Ascendis Pharma AS's website at https://www.ascendantresources.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...